Deltex Medical Group plc (AIM:DEMG) shares slipped 9% in spite of an update indicating that trading is on track with management forecasts.
Revenues in the half year were flat at £1.06 million with the medical components group posting an underlying profit during two months of the period with a continuing improvement for the second half.
Nigel Keen, Deltex Medical chairman, said Deltex had made good progress selling and creating a pipeline for the new TrueVue System into the UK and EU.
“The significant growth in our probe unit sales into the International markets shows that our plan is working.”
Shares dropped 0.02p to 0.15p, having spiked in recent weeks from the all-time lows around 0.1p reached in recent months.